Meridian Subsidiary Bioline, Launches ISOLATE II
Posted on February 06, 2013 at 07:10 AM EST
Bioline, The PCR Company, a wholly-owned subsidiary of Meridian Bioscience, Inc. (NASDAQ: VIVO ), is proud to announce the worldwide release of the high performance ISOLATE II range of nucleic acid